MXPA03007166A - Pirido-pirimidinas 6-sustituidas. - Google Patents

Pirido-pirimidinas 6-sustituidas.

Info

Publication number: MXPA03007166A
Authority: MX; Mexico
Prior art keywords: pyrimidines; substituted pyrido; pyrido; substituted
Prior art date: 2001-02-12

Application number

MXPA03007166A

Other languages

English (en)

Inventor

James Patrick Dunn

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-12

Filing date

2002-02-04

Publication date

2003-11-18

2002-02-04 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2003-11-18 Publication of MXPA03007166A publication Critical patent/MXPA03007166A/es

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

MXPA03007166A 2001-02-12 2002-02-04 Pirido-pirimidinas 6-sustituidas. MXPA03007166A (es)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US26837501P	2001-02-12	2001-02-12
US33465401P	2001-11-30	2001-11-30
PCT/EP2002/001106 WO2002064594A2 (en)	2001-02-12	2002-02-04	6-substituted pyrido-pyrimidines

Publications (1)

Publication Number	Publication Date
MXPA03007166A true MXPA03007166A (es)	2003-11-18

Family

ID=26953040

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA03007166A MXPA03007166A (es)	2001-02-12	2002-02-04	Pirido-pirimidinas 6-sustituidas.

Country Status (32)

Country	Link
US (3)	US6696566B2 (es)
EP (1)	EP1361880B1 (es)
JP (1)	JP4064818B2 (es)
KR (1)	KR100639772B1 (es)
CN (1)	CN100376571C (es)
AR (1)	AR035854A1 (es)
AT (1)	ATE305303T1 (es)
AU (1)	AU2002256615B2 (es)
BR (1)	BRPI0207172B8 (es)
CA (1)	CA2434834C (es)
CZ (1)	CZ20032416A3 (es)
DE (1)	DE60206363T2 (es)
DK (1)	DK1361880T3 (es)
ES (1)	ES2249574T3 (es)
HK (1)	HK1066170A1 (es)
HR (1)	HRP20030624B1 (es)
HU (1)	HU229604B1 (es)
IL (2)	IL156872A0 (es)
JO (1)	JO2410B1 (es)
MA (1)	MA26993A1 (es)
MX (1)	MXPA03007166A (es)
MY (1)	MY131518A (es)
NO (1)	NO326133B1 (es)
NZ (1)	NZ526961A (es)
PA (1)	PA8539201A1 (es)
PE (1)	PE20020976A1 (es)
PL (1)	PL366918A1 (es)
RU (1)	RU2269527C2 (es)
SK (1)	SK11322003A3 (es)
WO (1)	WO2002064594A2 (es)
YU (1)	YU63703A (es)
ZA (1)	ZA200305938B (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7053070B2 (en) *	2000-01-25	2006-05-30	Warner-Lambert Company	Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors
HU229604B1 (en)	2001-02-12	2014-02-28	Hoffmann La Roche	6-substituted pyrido-pyrimidines, process for their preparation and pharmaceutical compositions containing them
ATE314370T1 (de) *	2002-01-22	2006-01-15	Warner Lambert Co	2-(pyridin-2-ylamino)-pyrido(2,3-d)pyrimidin-7- one
EP1492790A1 (en)	2002-04-03	2005-01-05	F. Hoffmann-La Roche Ag	Imidazo fused compounds
DE60316581T2 (de)	2002-08-06	2008-07-03	F. Hoffmann-La Roche Ag	6-alkoxypyridopyrimidine als inhibitoren der p-38-map-kinase
US20040225077A1 (en)	2002-12-30	2004-11-11	Angiotech International Ag	Drug delivery from rapid gelling polymer composition
ES2401330T3 (es) *	2003-02-26	2013-04-18	Sugen, Inc.	Compuesto de heteroarilamino inhibidores de proteín quinasas
RU2005135329A (ru) *	2003-04-16	2006-08-10	Ф.Хоффманн-Ля Рош Аг (Ch)	Замещенные 7-азахиназолины
DK1685131T3 (da) *	2003-11-13	2007-07-09	Hoffmann La Roche	Hydroxyalkylsubstituerede pyrido-7-pyrimidin-7-oner
WO2006056863A1 (en) *	2004-11-23	2006-06-01	Ranbaxy Laboratories Limited	Pyrido’2, 3-d!pyrimidines as anti-inflammatory agents
US20060142312A1 (en) *	2004-12-23	2006-06-29	Pfizer Inc	C6-aryl and heteroaryl substituted pyrido[2,3-D] pyrimidin-7-ones
WO2006082492A1 (en) *	2005-02-02	2006-08-10	Ranbaxy Laboratories Limited	Azabicyclo derivatives as anti-inflammatory agents
ES2552804T3 (es) *	2005-05-04	2015-12-02	Evotec Ag	Compuestos heterocíclicos condensados, y sus composiciones y usos
CN101243081A (zh) *	2005-07-21	2008-08-13	霍夫曼-拉罗奇有限公司	作为PTP1B抑制剂的吡啶并[2,3-d]嘧啶-2,4-二胺化合物
RU2008108898A (ru) *	2005-08-09	2009-09-20	Айрм Ллк (Bm)	Соединения и композиции в качестве ингибиторов протеинкиназы
US8686002B2 (en)	2005-08-21	2014-04-01	AbbVie Deutschland GmbH & Co. KG	Heterocyclic compounds and their use as binding partners for 5-HT5 receptors
JO2783B1 (en) *	2005-09-30	2014-03-15	نوفارتيس ايه جي	Compounds 2-Amino-7, 8-dihydro-6H-Bayredo (3,4-D) Pyrimidine-5-Ones
WO2008150260A1 (en) *	2007-06-06	2008-12-11	Gpc Biotech, Inc.	8-oxy-2-aminopyrido (2, 3-d) pyrimidin-7-one derivatives as kinase inhibitors and anticancer agents
WO2008078249A1 (en) *	2006-12-21	2008-07-03	Ranbaxy Laboratories Limited	Anti-inflammatory agents
EP2152706A1 (en)	2007-05-07	2010-02-17	Amgen Inc.	Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as p38 modulators, process for their preparation, and their pharmaceutical use
JP2010529973A (ja)	2007-06-15	2010-09-02	エフ．ホフマン−ラロシュアーゲー	３−アミノ−ペンタン−１，５−ジオールの新規製造方法
US8367671B2 (en)	2008-03-21	2013-02-05	Amgen Inc.	Pyrazolo[3.4-B]pyrazine compounds as p38 modulators and methods of use as anti-inflamatory agents
EP2112150B1 (en)	2008-04-22	2013-10-16	Forma Therapeutics, Inc.	Improved raf inhibitors
CN102177161A (zh) *	2008-10-22	2011-09-07	霍夫曼-拉罗奇有限公司	Jnk的嘧啶基吡啶酮抑制剂
US8674095B2 (en)	2008-12-19	2014-03-18	Afraxis Holdings, Inc.	Compounds for treating neuropsychiatric conditions
US8372970B2 (en) *	2009-10-09	2013-02-12	Afraxis, Inc.	8-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders
CA2784749C (en)	2009-12-18	2017-12-12	E. Premkumar Reddy	Substituted pyrido[2,3-d]pyrimidin-7(8h)-ones and therapeutic uses thereof
JP6631616B2 (ja)	2014-07-26	2020-01-15	ノース・アンド・サウス・ブラザー・ファーマシー・インベストメント・カンパニー・リミテッド	ＣＤＫ阻害剤としての２−アミノ−ピリド［２，３−ｄ］ピリミジン−７（８Ｈ）−オン誘導体及びその使用
CN115105601A (zh) *	2016-06-08	2022-09-27	投资支持有限公司	用于治疗癌症的药物组合
LT3497103T (lt)	2016-08-15	2021-07-26	Pfizer Inc.	Piridopirimidinono cdk2/4/6 inhibitoriai
EP3500258A1 (en) *	2016-08-17	2019-06-26	Support-Venture GmbH	Method of preventing or treating hearing loss
WO2018132550A1 (en) *	2017-01-11	2018-07-19	The General Hospital Corporation	Voltage gated sodium channel imaging agents
MY202289A (en) *	2017-04-04	2024-04-22	Kinarus Ag	Methods of preventing or treating ophthalmic diseases
AU2018325442B2 (en) *	2017-08-31	2023-04-13	Dana-Farber Cancer Institute, Inc.	Inhibitors of EGFR and/or HER2 and methods of use
CA3128468A1 (en)	2017-10-05	2019-04-11	Fulcrum Therapeutics, Inc.	P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd
US10342786B2 (en)	2017-10-05	2019-07-09	Fulcrum Therapeutics, Inc.	P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
WO2020006210A1 (en) *	2018-06-27	2020-01-02	Tufts Medical Center, Inc.	Pyridopyrimidine compounds and methods of their use
AU2019300135A1 (en)	2018-07-13	2021-01-28	Kinarus Ag	Combinations of PPAR agonists and p38 kinase inhibitors for preventing or treating fibrotic diseases
TW202112368A (zh)	2019-06-13	2021-04-01	荷蘭商法西歐知識產權股份有限公司	用於治療有關dux4表現之疾病的抑制劑組合
US20230263803A1 (en)	2020-08-11	2023-08-24	Kinarus Ag	Methods of preventing or treating covid-19 and related viral diseases or disorders

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4215216A (en)	1979-04-18	1980-07-29	American Home Products Corporation	7,8-Dihydro-2,5,8-trisubstituted-7-oxo-pyrido[2,3-d]pyrimidine-6-carboxylic acid derivatives
US5037826A (en)	1986-10-15	1991-08-06	Schering Corporation	1-substituted naphthyridine and pyridopyrazine derivatives
GB8702758D0 (en) *	1987-02-06	1987-03-11	Wellcome Found	Treatment of disease
EP0278686A1 (en)	1987-02-07	1988-08-17	The Wellcome Foundation Limited	Pyridopyrimidines methods for their preparation and pharmaceutical formulations thereof
WO1993017682A1 (en)	1992-03-04	1993-09-16	Abbott Laboratories	Angiotensin ii receptor antagonists
EP0790997B1 (en) *	1994-11-14	2000-03-22	Warner-Lambert Company	6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
IL115256A0 (en)	1994-11-14	1995-12-31	Warner Lambert Co	6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
IL117923A (en)	1995-05-03	2000-06-01	Warner Lambert Co	Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
US5620981A (en)	1995-05-03	1997-04-15	Warner-Lambert Company	Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
AR004010A1 (es)	1995-10-11	1998-09-30	Glaxo Group Ltd	Compuestos heterociclicos
US6107300A (en)	1996-03-27	2000-08-22	Dupont Pharmaceuticals	Arylamino fused pyrimidines
US6147080A (en) *	1996-12-18	2000-11-14	Vertex Pharmaceuticals Incorporated	Inhibitors of p38
US5945422A (en)	1997-02-05	1999-08-31	Warner-Lambert Company	N-oxides of amino containing pyrido 2,3-D! pyrimidines
JP2001509805A (ja)	1997-02-05	2001-07-24	ワーナー−ランバート・コンパニー	細胞増殖阻害剤としてのピリド〔２，３−ｄ〕ピリミジンおよび４−アミノピリミジン
IL131618A0 (en)	1997-04-16	2001-01-28	Abbott Lab	5,7-Disubstituted aminopyrido [2,3-D] pyrimidine compounds and their use as adenosine kinase inhibitors
TW458977B (en) *	1997-04-16	2001-10-11	Abbott Lab	6,7-disubstituted-4-aminopyrido[2,3-D] pyrimidine compounds
AU741033B2 (en)	1997-04-16	2001-11-22	Abbott Laboratories	5,6,7-trisubstituted-4-aminopyridol(2,3-d)pyrimidine compounds
ID27589A (id)	1998-05-26	2001-04-12	Warner Lambert Comapny	Pirimidina bisiklik dan dihidropirimidina bisiklik 3,4 sebagai penghambat proliferasi selular
KR100415791B1 (ko)	1998-06-19	2004-01-24	화이자 프로덕츠 인코포레이티드	피롤로[2,3-디]피리미딘 화합물
ES2258431T3 (es)	1999-08-02	2006-09-01	F. Hoffmann-La Roche Ag	Proceso para la preparacion de derivados de benzotiofeno.
US7053070B2 (en) *	2000-01-25	2006-05-30	Warner-Lambert Company	Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors
IL151480A0 (en) *	2000-03-06	2003-04-10	Warner Lambert Co	5-alkylpyrido[2,3-d] pyrimidines tyrosine kinase inhibitors
US6518276B2 (en) *	2000-08-31	2003-02-11	Syntex (U.S.A.) Llc	7-oxo-pyridopyrimidines (II)
HU229604B1 (en)	2001-02-12	2014-02-28	Hoffmann La Roche	6-substituted pyrido-pyrimidines, process for their preparation and pharmaceutical compositions containing them
ATE314370T1 (de) *	2002-01-22	2006-01-15	Warner Lambert Co	2-(pyridin-2-ylamino)-pyrido(2,3-d)pyrimidin-7- one

2002
- 2002-02-04 HU HU0303458A patent/HU229604B1/hu unknown
- 2002-02-04 CZ CZ20032416A patent/CZ20032416A3/cs unknown
- 2002-02-04 KR KR1020037010562A patent/KR100639772B1/ko active IP Right Grant
- 2002-02-04 PL PL02366918A patent/PL366918A1/xx not_active Application Discontinuation
- 2002-02-04 SK SK11322003A patent/SK11322003A3/sk unknown
- 2002-02-04 NZ NZ526961A patent/NZ526961A/en unknown
- 2002-02-04 YU YU63703A patent/YU63703A/sh unknown
- 2002-02-04 DK DK02726103T patent/DK1361880T3/da active
- 2002-02-04 IL IL15687202A patent/IL156872A0/xx unknown
- 2002-02-04 DE DE60206363T patent/DE60206363T2/de not_active Expired - Lifetime
- 2002-02-04 BR BRPI0207172-0 patent/BRPI0207172B8/pt not_active IP Right Cessation
- 2002-02-04 ES ES02726103T patent/ES2249574T3/es not_active Expired - Lifetime
- 2002-02-04 AU AU2002256615A patent/AU2002256615B2/en not_active Expired
- 2002-02-04 AT AT02726103T patent/ATE305303T1/de active
- 2002-02-04 EP EP02726103A patent/EP1361880B1/en not_active Expired - Lifetime
- 2002-02-04 WO PCT/EP2002/001106 patent/WO2002064594A2/en not_active Application Discontinuation
- 2002-02-04 CA CA2434834A patent/CA2434834C/en not_active Expired - Lifetime
- 2002-02-04 RU RU2003125887/04A patent/RU2269527C2/ru not_active IP Right Cessation
- 2002-02-04 JP JP2002564525A patent/JP4064818B2/ja not_active Expired - Lifetime
- 2002-02-04 MX MXPA03007166A patent/MXPA03007166A/es active IP Right Grant
- 2002-02-04 CN CNB028048342A patent/CN100376571C/zh not_active Expired - Lifetime
- 2002-02-06 JO JO200212A patent/JO2410B1/en active
- 2002-02-08 PA PA20028539201A patent/PA8539201A1/es unknown
- 2002-02-08 PE PE2002000097A patent/PE20020976A1/es not_active Application Discontinuation
- 2002-02-11 AR ARP020100430A patent/AR035854A1/es unknown
- 2002-02-11 MY MYPI20020491A patent/MY131518A/en unknown
- 2002-02-11 US US10/073,845 patent/US6696566B2/en not_active Expired - Lifetime
2003
- 2003-07-10 IL IL156872A patent/IL156872A/en unknown
- 2003-07-31 ZA ZA2003/05938A patent/ZA200305938B/en unknown
- 2003-08-01 HR HR20030624A patent/HRP20030624B1/xx not_active IP Right Cessation
- 2003-08-11 NO NO20033540A patent/NO326133B1/no not_active IP Right Cessation
- 2003-08-11 MA MA27273A patent/MA26993A1/fr unknown
- 2003-11-25 US US10/722,703 patent/US7169794B2/en not_active Expired - Lifetime
2004
- 2004-11-19 HK HK04109141A patent/HK1066170A1/xx not_active IP Right Cessation
2007
- 2007-01-09 US US11/651,302 patent/US7449581B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NO326133B1 (no)	2008-10-06
HRP20030624B1 (en)	2007-03-31
DE60206363D1 (de)	2006-02-09
CZ20032416A3 (cs)	2004-07-14
ZA200305938B (en)	2005-01-26
SK11322003A3 (en)	2004-10-05
HRP20030624A2 (en)	2005-06-30
EP1361880A2 (en)	2003-11-19
KR100639772B1 (ko)	2006-10-30
NZ526961A (en)	2005-03-24
CA2434834A1 (en)	2002-08-22
HUP0303458A2 (hu)	2004-01-28
RU2269527C2 (ru)	2006-02-10
HU229604B1 (en)	2014-02-28
CN100376571C (zh)	2008-03-26
US20070135458A1 (en)	2007-06-14
PA8539201A1 (es)	2004-08-31
PL366918A1 (en)	2005-02-07
EP1361880B1 (en)	2005-09-28
IL156872A0 (en)	2004-02-08
WO2002064594A3 (en)	2003-01-09
BR0207172A (pt)	2004-03-30
US7169794B2 (en)	2007-01-30
KR20040018254A (ko)	2004-03-02
BRPI0207172B8 (pt)	2021-05-25
JP4064818B2 (ja)	2008-03-19
RU2003125887A (ru)	2005-03-20
MA26993A1 (fr)	2004-12-20
PE20020976A1 (es)	2002-10-29
HK1066170A1 (en)	2005-03-18
ATE305303T1 (de)	2005-10-15
DK1361880T3 (da)	2006-01-23
BRPI0207172B1 (pt)	2019-04-09
US6696566B2 (en)	2004-02-24
US20040116698A1 (en)	2004-06-17
US7449581B2 (en)	2008-11-11
HUP0303458A3 (en)	2012-12-28
CA2434834C (en)	2010-09-14
WO2002064594A2 (en)	2002-08-22
US20030171584A1 (en)	2003-09-11
AU2002256615B2 (en)	2007-09-13
NO20033540L (no)	2003-08-11
YU63703A (sh)	2006-05-25
IL156872A (en)	2009-07-20
JP2004525896A (ja)	2004-08-26
CN1503672A (zh)	2004-06-09
MY131518A (en)	2007-08-30
DE60206363T2 (de)	2006-07-06
ES2249574T3 (es)	2006-04-01
NO20033540D0 (no)	2003-08-11
JO2410B1 (en)	2007-06-17
AR035854A1 (es)	2004-07-21

Legal Events

Date	Code	Title	Description
2006-05-10	FG	Grant or registration

Publication	Publication Date	Title
MXPA03007166A (es)	2003-11-18	Pirido-pirimidinas 6-sustituidas.
ZA200208561B (en)	2003-05-19	Hydraulischer druckverstarker.
ZA200209547B (en)	2003-06-10	Bounce-reduced relay.
ZA200307646B (en)	2004-07-13	Benzamidine derivative.
ZA200306530B (en)	2004-11-22	Foamer.
HK1051639A1 (en)	2003-08-15	Buckle.
MXPA01009037A (es)	2003-11-18	I-bet.
MXPA03009583A (es)	2004-02-12	Ftalazinonas novedosas.
MXPA03007320A (es)	2003-12-04	Nuevos compuestos de pirimidina.
HK1048241A1 (en)	2003-03-28	Fryer.
HK1050549A1 (en)	2003-06-27	Heater.
ZA200208648B (en)	2003-10-27	Metal-polyurethane laminates.
MXPA03006603A (es)	2004-02-12	Agonista de subtipo de receptor 5-ht1a.
MXPA03005286A (es)	2003-10-06	METODO Y APARATO PARA SUPERVISAR PULSACION DE INSTALACION DE ORDEnA.
MXPA03008140A (es)	2003-12-12	Amidas de acido benzofuran-2-carboxilico sustituidas.
MXPA03008139A (es)	2003-12-12	Fluoralcoxifenilsulfonilureas sustituidas.
HK1050086A1 (en)	2003-06-06	Reference voltae circuit.
MXPA03008394A (es)	2004-01-29	Derivados de biuretano.
HK1061059A1 (en)	2004-09-03	Panel.
HK1059781A1 (en)	2004-07-16	New phenylpiperazines.
ZA200200597B (en)	2003-07-23	Combination theraphy.
HK1060608A1 (en)	2004-08-13	Latch.
ZA200205436B (en)	2003-03-26	Herbicidal methods.
HK1050120A1 (en)	2003-06-13	Watchband.
SI1361880T1 (sl)	2006-02-28	6-substituirani pirido-pirimidini